Ryman Healthcare Ltd Stock Net Income
| RYHTY Stock | USD 8.61 0.00 0.00% |
As of the 3rd of February, Ryman Healthcare holds the Coefficient Of Variation of 1108.2, variance of 1.24, and Risk Adjusted Performance of 0.0696. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ryman Healthcare, as well as the relationship between them.
Ryman Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ryman Healthcare's valuation are provided below:Ryman Healthcare Ltd does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Ryman |
Ryman Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ryman Healthcare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ryman Healthcare.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Ryman Healthcare on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Ryman Healthcare Ltd or generate 0.0% return on investment in Ryman Healthcare over 90 days. Ryman Healthcare is related to or competes with Sienna Senior, Raffles Medical, Trulieve Cannabis, Nippon Shinyaku, CStone Pharmaceuticals, and Life Healthcare. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the ... More
Ryman Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ryman Healthcare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ryman Healthcare Ltd upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0402 | |||
| Maximum Drawdown | 9.76 |
Ryman Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ryman Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ryman Healthcare's standard deviation. In reality, there are many statistical measures that can use Ryman Healthcare historical prices to predict the future Ryman Healthcare's volatility.| Risk Adjusted Performance | 0.0696 | |||
| Jensen Alpha | 0.0973 | |||
| Total Risk Alpha | 0.021 | |||
| Treynor Ratio | (0.61) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ryman Healthcare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ryman Healthcare February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0696 | |||
| Market Risk Adjusted Performance | (0.60) | |||
| Mean Deviation | 0.3774 | |||
| Coefficient Of Variation | 1108.2 | |||
| Standard Deviation | 1.11 | |||
| Variance | 1.24 | |||
| Information Ratio | 0.0402 | |||
| Jensen Alpha | 0.0973 | |||
| Total Risk Alpha | 0.021 | |||
| Treynor Ratio | (0.61) | |||
| Maximum Drawdown | 9.76 | |||
| Skewness | 1.01 | |||
| Kurtosis | 14.9 |
Ryman Healthcare Backtested Returns
At this stage we consider Ryman Pink Sheet to be not too volatile. Ryman Healthcare maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. We have found seventeen technical indicators for Ryman Healthcare, which you can use to evaluate the volatility of the company. Please check Ryman Healthcare's Risk Adjusted Performance of 0.0696, variance of 1.24, and Coefficient Of Variation of 1108.2 to confirm if the risk estimate we provide is consistent with the expected return of 0.13%. Ryman Healthcare has a performance score of 8 on a scale of 0 to 100. The company holds a Beta of -0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Ryman Healthcare are expected to decrease at a much lower rate. During the bear market, Ryman Healthcare is likely to outperform the market. Ryman Healthcare right now holds a risk of 1.16%. Please check Ryman Healthcare information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if Ryman Healthcare will be following its historical price patterns.
Auto-correlation | -0.26 |
Weak reverse predictability
Ryman Healthcare Ltd has weak reverse predictability. Overlapping area represents the amount of predictability between Ryman Healthcare time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ryman Healthcare price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Ryman Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Ryman Healthcare Ltd reported net income of 692.87 M. This is 103.02% higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The net income for all United States stocks is 21.35% lower than that of the firm.
Ryman Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ryman Healthcare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ryman Healthcare could also be used in its relative valuation, which is a method of valuing Ryman Healthcare by comparing valuation metrics of similar companies.Ryman Healthcare is currently under evaluation in net income category among its peers.
Ryman Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.91 B | |||
| Shares Outstanding | 100 M | |||
| Price To Earning | 10.13 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 3.74 X | |||
| Revenue | 503.76 M | |||
| Gross Profit | 42.52 M | |||
| EBITDA | 788.44 M | |||
| Net Income | 692.87 M | |||
| Cash And Equivalents | 47.88 M | |||
| Cash Per Share | 0.48 X | |||
| Total Debt | 2.58 B | |||
| Debt To Equity | 0.76 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 36.28 X | |||
| Cash Flow From Operations | 585.98 M | |||
| Earnings Per Share | 3.82 X | |||
| Price To Earnings To Growth | 2.36 X | |||
| Number Of Employees | 6.8 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 10.97 B | |||
| Retained Earnings | 1.28 B | |||
| Working Capital | 114 M | |||
| Current Asset | 221 M | |||
| Current Liabilities | 107 M | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.84 % | |||
| Net Asset | 10.97 B | |||
| Last Dividend Paid | 0.22 |
About Ryman Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ryman Pink Sheet Analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.